# Colposeptine for the Treatment of Bacterial Vaginosis

> **NCT01153958** · PHASE4 · TERMINATED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 133 (actual)

## Conditions studied

- Vaginosis, Bacterial

## Interventions

- **DRUG:** Colposeptine
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT01153958
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01153958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01153958, "Colposeptine for the Treatment of Bacterial Vaginosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01153958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*